|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | HCV-Related Nervous System Disorders显示文摘 | Salvatore Monaco Sergio Ferrari Alberto Gajofatto Gianluigi Zanusso Sara Mariotto Domenico Sansonno | 2012 | Clinical and Developmental Immunology2012，，： | 4 |
| 2 | The expression and potential function of cellular prion protein in human lymphocytes显示文摘 | li R liu D Zanusso G | 2001 | Cell Immunol2001，207，： | 1 |
| 3 | Clinical and biomarker assessment of demyelinating events suggesting multiple sclerosis显示文摘 | Gajofatto A Bongianni M Zanusso G | 2013 | Acta Neurol Scand2013，128，5： | 1 |
| 4 | Accuracy of diagnostic criteria for sporadic Creutzfeldt-Jakob disease among rapidly progressive dementia 显示文摘 | Tagliapietra M Zanusso G Fiorini MA | 2013 | J Alzheimers Dis2013，34，1： | 1 |
| 5 | Cerebrospinal fluid markers in sporadic Creutzfeldt-Jakob disease显示文摘 | Zanusso G Fiorini M Ferrari S | 2011 | Int J Mol Sci2011，12，9： | 1 |
| 6 | Prion protein expression in different species:Analysis with a panel of new mAbs 显示文摘 | Zanusso G Liu D Ferrari S Hegyi I Yin X Aguzzi A | 1998 | Proc Natl Acad Sci USA1998，95，15： | 1 |
| 7 | Accuracy of diagnostic criteria for sporadic creutzfeldt-jakob disease among rapidly progressive dementia显示文摘 | Tagliapietra M Zanusso G Fiorini M | 2013 | J Alzheimers Dis2013，34，1： | 1 |
| 8 | Clinical trials of genetherapy, virotherapy,and immunotherapy for malignant gliomas显示文摘 | Barzon L Zanusso M Colombo F | 2006 | Cancer Gerve Thef2006，13，： | 1 |
| 9 | The expression and potential function of cellular prion protein in human lymphocytes显示文摘 | Li R Liu D Zanusso G | 2001 | Cell Immunol2001，207，1： | 1 |
| 10 | Clinical and biomarker assessment of demyelinating events suggesting multiple sclerosis显示文摘 | Gajofatto A Bongianni M Zanusso G et a1 | 2013 | Acta Neurol Scand2013，128，5： | 1 |
| 11 | Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders:Advances in 2015显示文摘Since its identification in 1989, hepatitis C virus(HCV) has emerged as a worldwide health problem with roughly 185 million chronic infections, representing individuals at high risk of developing cirrhosis and liver cancer. In addition to being a frequent cause of morbidity and mortality due to liver disease, HCV has emerged as an important trigger of lymphoproliferative disorders, owing to its lymphotropism, and of a wide spectrum of extrahepatic manifestations(HCV-EHMs) affecting different organ systems. The most frequently observed HCV-EHMs include mixed cryoglobulinemia and cryoglobulinemic vasculitis, B-cell non-Hodgkin's lymphoma, nephropathies, thyreopathies, type 2 diabetes mellitus, cardiovascular diseases, and several neurological conditions. In addition, neuropsychiatric disorders and neurocognitive dysfunction are reported in nearly 50% of patients with chronic HCV infection, which are independent of the severity of liver disease or HCV replication rates. Fatigue, sleep disturbance, depression and reduced quality of life are commonly associated with neurocognitive alterations in patients with non-cirrhotic chronic HCV infection, regardless of the stage of liver fibrosis and the infecting genotype. These manifestations, which are the topic of this review, typically occur in the absence of structural brain damage or signal abnormalities on conventional brain magnetic resonance imaging(MRI), although metabolic and microstructural changes can be detected by in vivo proton magnetic resonance spectroscopy, perfusion-weighted and diffusion tensorMRI, and neurophysiological tests of cognitive processing. Several lines of evidence, including comparative and longitudinal neuropsychological assessments in patients achieving spontaneous or treatment-induced viral clearance, support a major pathogenic role for HCV in neuropsychiatric and neurocognitive disorders. | Salvatore Monaco Sara Mariotto Sergio Ferrari Massimiliano Calabrese Gianluigi Zanusso Alberto Gajofatto Domenico Sansonno Franco Dammacco | 2015 | World Journal of Gastroenterology2015，21，42： | 1 |
| 12 | Are cerebrospinal fluid biomarkers useful in predicting the prognosis of multiple sclerosis patients 显示文摘 | Gajofatto A Bongianni M Zanusso G | 2011 | Int J Mol Sci2011，12，11： | 1 |
| 13 | Clinical trials of gene therapy,virotherapy,and immunotherapy for malignant gliomas显示文摘 | Barzon L Zanusso M Colombo F | 2006 | Cancer Gene Ther2006，13，6： | 1 |
| 14 | Clinical trials of gene therapy, virotherapy, and immunotherapy for malignant gliomas显示文摘 | Barzon L Zanusso M Colombo F | 2006 | J Cancer Gene Ther2006，13，6： | 1 |
| 15 | Clinical trials of gone therapy, virotherapy, and immunotherapy for malignant gliomas 显示文摘 | BARZON L ZANUSSO M COLOMBO F | 2006 | Cancer Gone Ther2006，13，6： | 1 |
| 16 | Increased expression of the normal cellular isoform of prion protein in inclusion-body myositis, inflammatory myopathies and denervation atrophy 显示文摘 | Zanusso G Vattemi G Ferrari S | 2001 | Brain Pathol2001，，11： | 1 |
| 17 | Identification of a sec- ond bovine amyloidotic spongiform encephalopathy: molecular similarities with sporadic Creutzfeldt-Jakob disease 显示文摘 | Casalone C Zanusso G Acutis P | 2004 | Proc Natl Aead Sci U S A2004，101，9： | 1 |
| 18 | Clinical and biomarker assessment o{ demyelinating events suggesting multiple sclerosis 显示文摘 | Gajofatto A Bongianni M Zanusso G | 2013 | Acta Neurol Scand2013，128，5： | 1 |
| 19 | HCV-Related Nervous System Disorders显示文摘 | Salvatore Monaco Sergio Ferrari Alberto Gajofatto Gianluigi Zanusso Sara Mariotto Domenico Sansonno | 2012 | Clinical and Developmental Immunology2012，，： | 1 |
| 20 | Metabo lizable energy levels for broilers(1 to 21 days)maintained under a thermonertralenviroment显示文摘 | Zanusso J T Oliveiva R F M Donzele J L | 1999 | Revista brasileiva De Zoo tecnia1999，28，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员